Skip to content

Benefits of Effective Exercise for knee Pain - The BEEP main trial

The BEEP study: a trial aiming to improve the effectiveness of physiotherapy-led exercise for knee pain in older adults in primary care

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN93634563
Enrollment
500
Registered
2011-09-29
Start date
2010-11-19
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal, All Diseases Musculoskeletal Diseases Pain in joint: knee

Interventions

Individually Tailored Exercise Patients will receive between 6-8 face-to-face treatment sessions with a physiotherapist within 12 weeks Targeted Exercise Adherence Gro

Sponsors

Keele University (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 45 years and over 2. Knee pain or stiffness in one or both knees 3. Primary care consulters willing to particpate in the study 4. Able to give informed consent 5. Has access to telephone 6. Able to read and write in English 7. Target Gender: Male & Female

Exclusion criteria

Exclusion criteria: 1. Those with potentially serious pathology 2. Those on a waiting list to have a hip or knee replacement to affected side 3. Those who have already had a hip or knee replacement to affected side 4. When the knee problem is caused by a recent sports injury, fall or accident 5. Those for whom exercise interventions are contra-indicated 6. Those who have had an exercise programme from a physiotherapist, or an injection in the last 3 months 7. Those living in a nursing home

Design outcomes

Primary

MeasureTime frame
Pain and Function from the WOMAC (Western Ontario and McMaster Universities) Index of Osteoarthritis WOMAC is collected at baseline, 3, 6, 9, 18 and 36 months

Secondary

MeasureTime frame
1. 7-day accelerometry; Timepoint(s): Collected at baseline, 3, 6, 9, 18 and 36 months 2. Anxiety (GAD-7); Timepoint(s): Collected at baseline, 3, 6, 9, 18 and 36 months 3. Body Mass Index; Timepoint(s): Collected at baseline, 3, 6, 9, 18 and 36 months 4. Cost-effectiveness; Timepoint(s): Collected at 3, 6, 9, 18 and 36 months 5. Depression (PHG-8); Timepoint(s): Collected at baseline, 3, 6, 9, 18 and 36 months 6. Exercise adherence; Timepoint(s): Collected at 3, 6, 9, 18 and 36 months 7. Healthcare utilisation (self report & Med Rec Review); Timepoint(s): Collected at 6, 18 and 36 months 8. ICE CAP-A capabilities; Timepoint(s): Collected at baseline, 6 and 18 months 9. Illness Perceptions (IPQ); Timepoint(s): Collected at baseline, 3 and 6 months 10. Medication usage; Timepoint(s): Collected at baseline, 3, 6, 9, 18 months 11. OMERACT-OARSI; Timepoint(s): Collected at baseline, 3, 6, 9, 18 and 36 months 12. Overall health status (EQ-SD); Timepoint(s): Collected at baseline, 3, 6, 9, 18 and 36 months 13. Patient's Global Assessment of Change; Timepoint(s): Collected at 3, 6, 9, 18 and 36 months 14. Physical activity levels (self report PASE); Timepoint(s): Collected at baseline, 3, 6, 9, 18 and 36 months 15. Self-efficacy for exercise (SEE); Timepoint(s): Collected at baseline, 3 and 6 months

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 20, 2026